| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 64 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 58 |
| 2 | TACROLIMUS OINTMENT 0.1% | 58 |
| 3 | MYCOPHENOLATE MOFETIL | 51 |
| 4 | PREDNISOLONE | 39 |
| 5 | PREDNISOLONE ORAL | 39 |
| 6 | PREDNISOLONE ORAL SOLUTION | 39 |
| 7 | PREDNISONE | 29 |
| 8 | ADALIMUMAB | 11 |
| 9 | CYCLOSPORINE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ITRACONAZOLE | 7 | 0.0006 |
| 1 | AMIKACIN SULFATE | 1 | 0.0006 |
| 2 | POSACONAZOLE | 9 | 0.0005 |
| 3 | TACROLIMUS OINTMENT 0.1% | 58 | 0.0005 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 58 | 0.0005 |
| 5 | ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) | 1 | 0.0004 |
| 6 | NITRIC OXIDE | 2 | 0.0004 |
| 7 | TACROLIMUS | 64 | 0.0004 |
| 8 | MYCOPHENOLATE MOFETIL | 51 | 0.0004 |
| 9 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 77 |
| 1 | Azole Antifungal [EPC] | 32 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 3 | Calcineurin Inhibitor Immunosuppressant [EPC] | 11 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 5 | Purine Antimetabolite [EPC] | 9 |
| 6 | Vitamin C [EPC] | 9 |
| 7 | Osmotic Laxative [EPC] | 8 |
| 8 | Interleukin-12 Antagonist [EPC] | 7 |
| 9 | Interleukin-23 Antagonist [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 5 | 0.0002 |
| 2 | Azole Antifungal [EPC] | 32 | 0.0002 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 2 | 0.0002 |
| 5 | Penem Antibacterial [EPC] | 4 | 0.0001 |
| 6 | Vitamin K [EPC] | 1 | 0.0001 |
| 7 | Sigma-1 Agonist [EPC] | 1 | 0.0001 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 9 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |